Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Alvogen, Inc. Company Profile

21:20 EDT 30th July 2014 | BioPortfolio

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic selection of products, partners and markets, and the utilization of a consolidated global supply chain. The company has more than 130 pharmaceutical products in development and registration with several products expected to be launched in 2010. The product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of Oncology, Cardiology, Respiratory, Neurology and Gastroenterology.


News Articles [11 Associated News Articles listed on BioPortfolio]

Alvogen launches infliximab biosimilar in Europe

US generics company Alvogen announced on 13 February 2014 that it had launched the infliximab biosimilar Inflectra in Central and Eastern Europe in collaboration with Hospira.

Pamplona buys majority stake in US generic firm Alvogen

Pamplona Capital Management has as acquired a majority stake in privately-held US company Alvogen, which it says is one of the fastest growing generics companies in the pharmaceutical industry.

Alvogen sells majority ownership to private equity firm Pamplona

Pamplona Capital Management’s Private Equity Fund III bought the majority stake in privately held Alvogen Inc., which sells generics, biosimilars, and OTC medicines.

Alvogen launches first biosimilar monoclonal antibody Inflectra in Europe

US-based specialty pharmaceutical firm Alvogen has launched a biosimilar monoclonal antibody (mAb) therapy 'Inflectra (Infliximab)' in Central and Eastern Europe.

Alvogen launches Inflectra into Central and Eastern Europe

Alvogen, the multinational pharmaceuticals company, today announced the launch of Inflectra (Infliximab) into Central and Eastern Europe. Inflectra, Europe's first biosimilar monoclonal antibody (mAb)...

Alvogen, Celltrion, Hospira sales and marketing update

Pamplona Capital Management Buys Majority Stake in Alvogen

LONDON and NEW YORK, April 2, 2014 /PRNewswire/ -- Pamplona Capital Management LLP "Pamplona" is pleased to announce that it has acquired a majority stake in Alvogen, one of the fastest growing gener...

European Notebook Notes Arrival Of CHMP Minutes And Biosimilar MAbs

CHMP has released for the first time the minutes of its meeting, and EMA has set up a new pharmacovigilance cluster with the FDA. A biosimilar infliximab product from Hospira and Alvogen has become th...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Alvogen Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen Pharma US, Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen, Inc. Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

More Information about "Alvogen, Inc." on BioPortfolio

We have published hundreds of Alvogen, Inc. news stories on BioPortfolio along with dozens of Alvogen, Inc. Clinical Trials and PubMed Articles about Alvogen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alvogen, Inc. Companies in our database. You can also find out about relevant Alvogen, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Relevant Topics

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.  Cancer sometimes begins in one part of the body before spre...

Cardiology
Latest News Clinical Trials Research Drugs Reports Corporate
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record